Growth Metrics

Omeros (OMER) Current Deferred Revenue (2010 - 2026)

Omeros recorded quarterly Current Deferred Revenue of $2.8 million in Q1 2026, up 13.99% quarter-over-quarter from $2.5 million in Q4 2025.

Omeros' Current Deferred Revenue history runs 9 years deep, the most recent figure standing at $2.8 million for Q1 2026.

  • In Q1 2026, Current Deferred Revenue changed N/A year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (changed N/A YoY), while the FY2025 annual figure was $2.5 million, up 1251.37% from the prior year.
  • Current Deferred Revenue came in at $2.8 million for Q1 2026 at Omeros, up from $2.5 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $2.8 million in Q1 2026 to a low of $183000.0 in Q4 2024.
  • A 3-year average of $1.8 million and a median of $2.5 million in 2025 frame the typical range for Current Deferred Revenue.
  • On a YoY basis, Current Deferred Revenue climbed as much as 1251.37% in 2025 and fell as far as 1251.37% in 2025.
  • Omeros' Current Deferred Revenue stood at $183000.0 in 2024, then surged by 1251.37% to $2.5 million in 2025, then rose by 13.99% to $2.8 million in 2026.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $2.8 million, $2.5 million, and $183000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.82 Mn
Dec 31, 2025 2.47 Mn
Dec 31, 2024 183,000.00
Sep 30, 2017 381,000.00
Jun 30, 2017 288,000.00
Dec 31, 2016 102,000.00
Mar 31, 2013 1.83 Mn
Dec 31, 2012 970,000.00
Sep 30, 2012 2.41 Mn
Jun 30, 2012 3.74 Mn
Mar 31, 2012 5.00 Mn
Dec 31, 2011 2.00 Mn
Sep 30, 2011 6.28 Mn
Jun 30, 2011 6.79 Mn
Dec 31, 2010 8.01 Mn